Century Therapeutics, Inc. Common Stock (NASDAQ: IPSC) last traded at $1.47, up 0.68% on the session. The quote above updates while this page is open; the figures below are drawn from Century Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Century Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker IPSC. Its market capitalisation is $266.18 million.
Valuation measures for Century Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $266.18M |
|---|---|
| Enterprise value | $271.20M |
| Price / sales | 2.44 |
| Price / book | 1.15 |
| Beta | 1.95 |
Trailing-twelve-month figures tagged in Century Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $109.16M |
|---|---|
| Net income (TTM) | -$109.79M |
| Operating margin | -107.17% |
| Return on equity | -47.25% |
| Cash | $49.64M |
Range and volume for IPSC over the past 52 weeks.
| 52-week high | $3.04 |
|---|---|
| 52-week low | $0.435 |
| Volume | 817.0K |
| Average volume | 655.7K |
| Previous close | $1.46 |
Invest a chosen dollar amount in Century Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell IPSC.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.